MedPath
NMPA Approval

丹红化瘀口服液

国药准字Z10960051

August 7, 2019

Drug Information

丹红化瘀口服液

白云山

合剂

每支装10ml

中药

August 7, 2019

Company Information

Manufacturing Company

广州市沙太北路389号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

丹红化瘀口服液 - NMPA 批准文号 | MedPath